A Phase Ib/II Study of Trovocabtagene Autoleucel (C-CAR088), an Anti-BCMA CAR T-Cell Therapy in Relapsed or Refractory Multiple Myeloma

被引：0
|
作者：
An, Gang [1 ]
Xu, Yan [1 ]
Yi, Shuhua [1 ]
Lyu, Rui [1 ]
Huang, Jiaqi [2 ]
Li, Wensi [2 ]
Zhang, Yiran [2 ]
Lan, Liping [2 ]
Qiu, Lugui [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol,Haihe Lab Cell Ecosyst, Tianjin, Peoples R China
[2] Shanghai AbelZeta Ltd, Shanghai, Peoples R China
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-194774
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：7235 / 7236
页数：2
相关论文
共 50 条
  • [1] Phase 1 study of C-CAR088, a novel humanized anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma
    Qu, Xiaoyan
    An, Gang
    Sui, Weiwei
    Wang, Tingyu
    Zhang, Xian
    Yang, Junfang
    Zhang, Yan
    Zhang, Lu
    Zhu, Dan
    Huang, Jiaqi
    Zhu, Shigui
    Yao, Xin
    Li, Jing
    Zheng, Chengxiao
    Zhu, Kevin
    Wei, Yutian
    Lv, Xiaoteng
    Lan, Liping
    Yao, Yihong
    Zhou, Daobin
    Lu, Peihua
    Qiu, Lugui
    Li, Jianyong
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (09)
  • [2] Updated Phase 1 Results of C-CAR088, an Anti-BCMA CAR T-Cell Therapy in Relapsed or Refractory Multiple Myeloma
    Qu, Xiaoyan
    An, Gang
    Sui, Weiwei
    Wang, Tingyu
    Zhang, Xian
    Yang, Junfang
    Zhang, Yan
    Zhang, Lu
    Zhu, Judy
    Huang, Jiaqi
    Li, Jing
    Zheng, Shirley
    Zhu, Kevin
    Lan, Liping
    Chen, Shiyi
    Humphries, Michael
    Yao, Yihong
    Zhou, Daobin
    Lu, Peihua
    Qiu, Lugui
    Li, Jianyong
    BLOOD, 2021, 138 : 1830 - +
  • [3] An Anti-Bcma CAR T-Cell Therapy (C-CAR088) Shows Promising Safety and Efficacy Profile in Relapsed or Refractory Multiple Myeloma
    An, Gang
    Sui, Weiwei
    Wang, Tingyu
    Qu, Xiaoyan
    Zhang, Xian
    Yang, Junfang
    Zhang, Yan
    Zhang, Lu
    Zhu, Judy
    Zheng, Chengxiao
    Yan, Xiuxiu
    Lv, Xiaoteng
    Lan, Liping
    Yang, Dingzhu
    Huo, Ningning
    Han, Ting
    Zhao, Dijun
    Qin, Shichao
    Wu, Junfeng
    Yao, Xin
    Zhu, Shigui
    Ren, Jiaqiang
    Zhang, Li
    Huang, Jiaqi
    Humphries, Michael
    Yao, Yihong
    Zhou, Daobin
    Li, Jianyong
    Lu, Peihua
    BLOOD, 2020, 136
  • [4] Ciltacabtagene autoleucel: The second anti-BCMA CAR T-cell therapeutic armamentarium of relapsed or refractory multiple myeloma
    Chekol Abebe, Endeshaw
    Yibeltal Shiferaw, Mestet
    Tadele Admasu, Fitalew
    Asmamaw Dejenie, Tadesse
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [5] Anti-BCMA CAR T-Cell Therapy in Multiple Myeloma
    Quintas-Cardama, Alfonso
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (03):
  • [6] Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
    Raje, Noopur
    Berdeja, Jesus
    Lin, Yi
    Siegel, David
    Jagannath, Sundar
    Madduri, Deepu
    Liedtke, Michaela
    Rosenblatt, Jacalyn
    Maus, Marcela V.
    Turka, Ashley
    Lam, Lyh-Ping
    Morgan, Richard A.
    Friedman, Kevin
    Massaro, Monica
    Wang, Julie
    Russotti, Greg
    Yang, Zhihong
    Campbell, Timothy
    Hege, Kristen
    Petrocca, Fabio
    Quigley, M. Travis
    Munshi, Nikhil
    Kochenderfer, James N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (18): : 1726 - 1737
  • [7] Immunoglobulin isotype switch after anti-BCMA CAR T-cell therapy for relapsed or refractory multiple myeloma
    Liang, Zhiyu
    Li, Ping
    Kang, Liqing
    Zhou, Lili
    Xu, Yang
    Ye, Shiguang
    Du, Juan
    Li, Bing
    Wang, Yiwen
    Yu, Lei
    Qian, Wenbin
    Liang, Aibin
    BLOOD ADVANCES, 2022, 6 (01) : 293 - 296
  • [8] A phase I study of anti-BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia
    Li, Chunrui
    Cao, Wenyue
    Que, Yimei
    Wang, Qiuxiang
    Xiao, Yi
    Gu, Chaojiang
    Wang, Di
    Wang, Jue
    Jiang, Lijun
    Xu, Hao
    Xu, Jinhuan
    Zhou, Xiaoxi
    Hong, Zhenya
    Wang, Na
    Huang, Liang
    Zhang, Shangkun
    Chen, Liting
    Mao, Xia
    Xiao, Min
    Zhang, Wei
    Meng, Li
    Cao, Yang
    Zhang, Tongcun
    Li, Jian
    Zhou, Jianfeng
    CLINICAL AND TRANSLATIONAL MEDICINE, 2021, 11 (03):
  • [9] Anti-BCMA CAR-T cell immunotherapy for relapsed or refractory multiple myeloma
    Zhang, Xiaohui
    Ouyang, Chenxi
    Sun, Guofeng
    Liu, Hongfeng
    Qi, Junyuan
    Suo, Xiaohui
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 26 (04)
  • [10] Humoral immune reconstitution after anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma
    Wang, Ying
    Li, Chunrui
    Xia, Jieyun
    Li, Ping
    Cao, Jiang
    Pan, Bin
    Tan, Xu
    Li, Hujun
    Qi, Kunming
    Wang, Xiangmin
    Shi, Ming
    Jing, Guangjun
    Yan, Zhiling
    Cheng, Hai
    Zhu, Feng
    Sun, Haiying
    Sang, Wei
    Li, Depeng
    Zhang, Xi
    Li, Zhenyu
    Zheng, Junnian
    Liang, Aibin
    Zhou, Jianfeng
    Xu, Kailin
    BLOOD ADVANCES, 2021, 5 (23) : 5290 - 5299
12345